Skip to content Skip to sidebar Skip to footer
Subscribe Now
PharmaShots Interview Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients with NSCLC at ASCO 2022
VIEWPOINTS

PharmaShots Interview: Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients with NSCLC at ASCO 2022

Shots: Kathy spoke about the major outcomes from the real-world evidence data presented at the ASCO 2022 Kathy also emphasized on how next-generation sequencing can improve genomic testing The interview gives a view of Thermo Fisher’s vision to bring targeted sequencing that provides faster results for clinicians Smriti: Tell us in detail about the key…
July 20, 20220Comments

Read more

PharmaShots Interview Mahesh Karande, CEO of Omega Therapeutics Shares Insights from the Preclinical Data Presented at the AACR 2022
VIEWPOINTS

PharmaShots Interview: Mahesh Karande, CEO of Omega Therapeutics Shares Insights from the Preclinical Data Presented at the AACR 2022

Shots: Mahesh talked about the data presented on its lead candidate in hepatocellular carcinoma at the AACR 2022 Mahesh also spoke about Omega’s drug-development platform that identifies and targets specific and unique DNA sequences of regulatory elements  The interview gives a profound grip on Omega’s development strategies to use mRNA therapeutics as a new class…
July 19, 20220Comments

Read more

Exclusive_Barbara Klencke_2022
EXCLUSIVE

Barbara Klencke, CMO at Sierra Oncology (now GSK) Shares Insights on the Significant benefits obtained from the Pivotal Myelofibrosis Study

Shots: Barbara gave a comprehensive view of the P-III (MOMENTUM) clinical study results which evaluates its lead candidate in myelofibrosis Sierra is now acquired by GSK (completed on 1st July 2022) resulting in GSK commercializing this prime product once approved The interview outlines Sierra’s (now GSK) vision to develop transformative therapies for rare cancers Smriti: Thank…
July 18, 20220Comments

Read more

Innovative Digital Therapeutics Top 20 2021
TOP 20

Top Innovative Digital Therapeutics Companies of 2021

Shots: The past few years have shown an accelerated development in the digital therapeutics market through various applications, tracking devices, and telemedicine being integrated into digital therapies Digital therapeutics provided powerful tools to maintain the public healthcare system during the Covid-19 pandemic for the people to access treatments for both physical & psychological conditions at home…
July 14, 20220Comments

Read more

PharmaShots Interview Dr. Bassem Maximos Shares Insights from New Research on Evofem’s Non-Hormonal Contraceptive Gel, P-III (AMPOWER) Study
VIEWPOINTS

PharmaShots Interview: Dr. Bassem Maximos Shares Insights from New Research on Evofem’s Non-Hormonal Contraceptive Gel, P-III (AMPOWER) Study

Shots: Bassem spoke about the new data presented in a poster presentation  at the ACOG annual meeting The data was based on the P-III (AMPOWER) study, which evaluates Evofem’s nonhormonal contraceptive gel to prevent pregnancy The interview gives an understanding of how Evofem is developing innovative products to improve women's health  Smriti: Please highlight the study…
July 13, 20220Comments

Read more

Exclusive_Kyle Forcier_2022
EXCLUSIVE

Kyle Forcier, Senior Director of Life Sciences Product Marketing at Model N Shares Insights on How Model N Helps Life Sciences Companies Navigate Greater Compliance Pressure

Shots: Kyle Forcier gave a detailed view of the Spring 2022 product release by Model N and how it will be a practical solution for the Pharmaceutical and MedTech companies Kyle also spoke about Model N’s Revenue Cloud, which can empower MedTech Sales with better revenue recognition The interview gives a glimpse of Model N’s…
July 11, 20220Comments

Read more

PharmShots Interview In Conversation with Nancy Holekamp, Director of Retina Services, Where she Shares Insights on The Results of the Global Survey to Find the Impact of Geographic Atrophy
VIEWPOINTS

PharmShots Interview: In Conversation with Nancy Holekamp, Director of Retina Services, Where she Shares Insights on The Results of the Global Survey to Find the Impact of Geographic Atrophy

Shots: Nancy spoke about the results from the Geographic Atrophy Insights Survey (GAINS) Nancy also talked about the emotional burden on the patients and the devastating impact on independence caused by vision loss  The global survey was conducted by The Harris Poll on behalf of Apellis Pharmaceuticals to find the impact of GA which is a…
July 6, 20220Comments

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]